SILEXION THERAPEUTICS CORP Increase (Decrease) in Accounts Payable, Trade
SILEXION THERAPEUTICS CORP (SLXN) reported Increase (Decrease) in Accounts Payable, Trade of $268.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was $268.00K.
- SILEXION THERAPEUTICS CORP increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $125.00K.
- SILEXION THERAPEUTICS CORP increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was -$159.00K, a 221.37% decline year-over-year.
- SILEXION THERAPEUTICS CORP increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $254.00K, a 50.87% decline year-over-year.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | $268.00K 10-Q · filed 2026-08-14 | $393.00K 10-Q · filed 2026-08-14 | $234.00K derived: sum of 3 quarters · filed 2026-08-14 | $488.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $125.00K S-1/A · filed 2026-08-10 | -$34.00K derived: sum of 2 quarters · filed 2026-08-10 | $220.00K derived: sum of 3 quarters · filed 2026-08-10 | $190.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$159.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $95.00K derived: sum of 2 quarters · filed 2026-08-10 | $65.00K derived: sum of 3 quarters · filed 2026-08-14 | -$142.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | $254.00K 10-Q · filed 2025-11-12 | $224.00K derived: sum of 2 quarters · filed 2026-08-14 | $17.00K 10-Q · filed 2025-11-12 | $148.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$30.00K 10-Q · filed 2026-08-14 | -$237.00K 10-Q · filed 2026-08-14 | -$106.00K derived: sum of 3 quarters · filed 2026-08-14 | $411.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$207.00K S-1/A · filed 2026-08-10 | -$76.00K derived: sum of 2 quarters · filed 2026-08-10 | $441.00K derived: sum of 3 quarters · filed 2026-08-10 | $478.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | $131.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $648.00K derived: sum of 2 quarters · filed 2026-08-10 | $685.00K derived: sum of 3 quarters · filed 2026-08-10 | $610.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $517.00K 10-Q · filed 2025-11-12 | $554.00K derived: sum of 2 quarters · filed 2025-11-12 | $479.00K 10-Q · filed 2025-11-12 | $484.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $37.00K 10-Q · filed 2025-08-12 | -$38.00K 10-Q · filed 2025-08-12 | -$33.00K derived: sum of 3 quarters · filed 2025-08-20 | $98.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | -$75.00K 10-Q · filed 2025-05-13 | -$70.00K derived: sum of 2 quarters · filed 2025-08-20 | $61.00K derived: sum of 3 quarters · filed 2025-08-20 | $9.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | $5.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | $136.00K derived: sum of 2 quarters · filed 2025-08-20 | $84.00K derived: sum of 3 quarters · filed 2025-08-20 | $79.00K 8-K · filed 2025-08-20 |
| 2023-09-30 | $131.00K 10-Q · filed 2024-11-14 | $79.00K derived: sum of 2 quarters · filed 2024-11-14 | $74.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$52.00K 10-Q · filed 2024-08-29 | -$57.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |